3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
CNS
1
Conditions
Brain Neoplasms
636
Glioblastoma
567
Glioma
406
Neuroblastoma
174
Neoplasms
123
Astrocytoma
107
Central Nervous System Neoplasms
104
Medulloblastoma
89
Breast Neoplasms
86
Meningioma
83
Carcinoma, Non-Small-Cell Lung
78
Melanoma
77
Lung Neoplasms
69
Sarcoma
66
Ependymoma
65
Neurofibromatosis 1
63
Recurrence
50
Oligodendroglioma
48
Neoplasm Metastasis
48
Osteosarcoma
47
Meningeal Carcinomatosis
46
Rhabdomyosarcoma
45
Diffuse Intrinsic Pontine Glioma
44
Pheochromocytoma
43
Rhabdoid Tumor
41
Paraganglioma
41
Gliosarcoma
40
Sarcoma, Ewing
39
Pancreatic Neoplasms
39
Colorectal Neoplasms
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Processes
×
CNS
×
1 year
×
Clear all
NCT07098806
2025-08-01
CA2024-LM-001
Plus Therapeutics
Phase 1
Recruiting
24 enrolled